Clive Dix becomes chairman of Crescendo Biologics

Published: 8-Jan-2010
Recruitment


Clive Dix has joined Crescendo Biologics as chairman and will work closely with Mike Romanos, chief scientific officer, to drive the development of the company and its proprietary antibody fragment technologies following recent seed round fundraising of £4.5m.

Dix has spent more than 20 years in the pharmaceutical and biotechnology business. He is chairman of the BioIndustry Association, the trade association for innovative enterprises in the UK's bioscience sector, and was previously co-founder and ceo of PowderMed, a vaccines development company acquired by Pfizer in November 2006. He was formerly senior vice president, r&d and a board member of PowderJect Pharmaceuticals until its acquisition by Chiron Vaccines in 2003.

Dix began his career in industry at Ciba-Geigy and then GlaxoWellcome, which he left as UK research director in 2001.

  • Companies:
  • Crescendo Biologics
See more

You may also like

Recruitment

Rentschler Biopharma continues hiring at global sites

Read more
During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel

Trending Articles

  1. Telesales Executive (Digital Media, Cosmetics & Pharma) HPCi Media – London, UK
  2. Beximco Pharma forms joint venture with Malaysia-based BioCare Manufacturing Beximco Pharmaceuticals, manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing
  3. Northern Industrial appoints Lynsey Doran
  4. People on the move
  5. Dr Richard Mason becomes ceo <p>Dr Richard Mason has joined 4-Antibody AG as ceo from venture capital firm Advent Venture Partners, an investor in 4-Antibody, where he has been an executive-in-residence. </p>

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Recruitment

Rentschler Biopharma continues hiring at global sites

During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel
Recruitment

Vetter Pharma invests $4.1m in Ravensburg training facility

The centre opened on September 14, with a small celebration held for management, training management and trainees.
Recruitment

Does pharma have a problem with inclusivity and innovation?

As we’ve seen only too clearly in recent weeks, the pharmaceutical industry is of paramount importance to the global economy and society. The collaboration regarding the COVID-19 pandemic is an example of the sector at its best, reports Stephen Frost, Founder, Frost Included
Recruitment

Cell Mogrify undergoes period of change

A cash injection and change in leadership gives momentum to the cell therapy company for direct cellular conversion platform
Recruitment

Novartis scoops Top Employer award

Novartis UK and its subsidiary, Sandoz, have been certified as ‘Top Employers’ of 2019 by Top Employers Institute
Recruitment

Retention, not just recruitment

Six ways to protect your company from the skills crisis
Recruitment

Particle Testing Authority (PTA) boosts company's thermal analysis capabilities

Particle Testing Authority (PTA), a division of Micromeritics Instrument Corporation, now has expanded thermal analysis capabilities with addition of Bryan Shaw to its team
Subscribe now